Ameritas Investment Partners, Inc. Alpine Immune Sciences, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.75 - $41.6 $8,236 - $19,302	464 Added 13.76%	3,835 $152,000
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $6,404 - $15,165	750 Added 28.62%	3,371 $64,000
Q2 2023 Aug 11, 2023	BUY	$6.84 - $11.91 $4,931 - $8,587	721 Added 37.95%	2,621 $26,000
Q1 2023 May 10, 2023	BUY	$7.0 - $8.75 $6,923 - $8,653	989 Added 108.56%	1,900 $14,000
Q2 2021 Aug 06, 2021	BUY	$8.81 - $15.03 $8,025 - $13,692	911 New	911 $8,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.